“Success of GLP-1 receptor agonists in kidney disease halts FLOW trial early.”
Document Type
Presentation
Publication Date
5-1-2024
Keywords
washington; spokane
Area of Special Interest
Kidney & Diabetes
Specialty/Research Institute
Endocrinology
Specialty/Research Institute
Nephrology
Comments
ADA